Fanconi anaemia and leukaemia - clinical and molecular aspects.
about
The inherited bone marrow failure syndromesA novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51The Fanconi anemia pathway and ubiquitinCytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cellsCentral nervous system abnormalities in Fanconi anaemia: patterns and frequency on magnetic resonance imaging.Fanconi anemia proteins and their interacting partners: a molecular puzzleCancer incidence in relatives of British Fanconi Anaemia patients.Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy.The investigation and management of chronic neutropenia in children.The many facets of H/ACA ribonucleoproteinsFancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cell maintenance.Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivorsHypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.Fanconi anemia: current management.Anesthesia and Fanconi anemia: a case report and review of literature.Fanconi anaemia genes and susceptibility to cancer.Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemiaAllogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemiaSCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem CellsFetal origins of hematopoietic failure in a murine model of Fanconi anemiaThe Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature.Contributions of DNA interstrand cross-links to aging of cells and organisms.Hereditary nonmelanoma skin cancerOxidative stress in Fanconi anemia hematopoiesis and disease progression.Fanconi anemia: a signal transduction and DNA repair pathway.Therapy-related myelodysplasia and acute myeloid leukemiaPotential of human induced pluripotent stem cells derived from blood and other postnatal cell types.Dermatological manifestations of inherited cancer syndromes in children.The Fanconi anemia ID2 complex: dueling saxes at the crossroads.Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.Discovering the hidden sub-network component in a ranked list of genes or proteins derived from genomic experiments.Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function.Myeloid lineage-selective growth of revertant cells in Fanconi anaemia.Ocular manifestations and visual functions in patients with Fanconi anaemia.Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know.Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.
P2860
Q26999046-EF834DE2-493F-4451-BDA5-3B943292E192Q28119199-FEB779B3-F443-41B6-99FD-EC8FB6BCF635Q28756516-54EF93B6-6A69-4E9D-91A4-44600FCF905DQ30497160-9923D309-6B0C-4855-B932-A621D05AFDB1Q30993537-9E51D493-E3C8-4C5B-B896-5819AA4724FFQ33353826-666A5ED5-4591-4E8B-AD0A-BDF1BD822CE7Q33368870-C857EAC3-E6F6-4B85-A738-EA6A9056C8D4Q33839812-DA946121-65A5-4802-B060-55B38CE5E4AEQ34316361-58578414-3B6E-4172-9718-CB9B117B0977Q34567825-F57670BB-2065-497E-BE04-CB2AF5AEF660Q35038202-96BB6E36-66BC-477B-8F65-7DA1E4C6C3FEQ35048836-B9272144-6F0E-4856-8D51-3B8EDE28F8DFQ35327266-E11004C3-34A3-42CD-AB16-F63F33EF3332Q35752656-044586F5-008D-4739-A920-C1BD7CF2770BQ35772723-8BE861E1-12BC-4E34-82BB-15FDCAB9BCE4Q36090202-E76A979A-F7FE-4583-9913-BB464022AA8DQ36269999-BDA40C57-A1DA-4F5A-9315-2E8D5DFE7001Q36570630-7AED34F0-E37C-48BB-974C-1E8100157956Q36602573-B5824A12-7016-42B7-89B2-05C55D088F66Q36677854-B9E1B997-F572-47BA-864D-C9BCC0DCAA82Q36792446-EDBE1835-6845-4DB3-B680-C6755DF0D124Q36818459-F72FCE50-BBB6-4AE1-A971-153ABF5E371CQ36818532-C879C656-0E2D-4AED-969B-AABF1A6CCD4DQ36867985-742F35DB-3483-4972-955A-FC9DD731FBD2Q36868596-3573F764-621E-48FD-A3CF-6F5E82294EF7Q37033646-DA25337D-45FE-40CA-8471-169DCD1D0380Q37136993-56CFC2F6-EFAC-47C1-9385-1DF28BD151FCQ37216681-6AF07318-C734-4C10-A8C6-0A5BCD0620A6Q37358559-9872A8B8-F8F7-4D6A-AB55-4C0C4E0D1BFEQ37402657-53CF33B0-5376-40DB-A3AA-0E495C77B9F8Q37772900-771EFE3D-3E0D-4F8F-B750-04E53170EE6FQ37802903-EA3069BC-0B41-4350-A0B1-8CC5753B2204Q38285213-8773F45A-8F2D-4BCE-A01A-F365B6176EF6Q38507121-57A48B7D-12A9-4CB7-A777-AC1E8BF2928BQ41518046-4F481AF3-5114-4D6A-B8EE-F53781C0EDD7Q41840189-6C721D0A-C3D1-48FC-8249-749BE138EBE3Q43559622-CB3A5A5D-850F-452A-8934-16D8B7AAD02CQ45239949-4B8E66A6-2528-4D8E-8197-E8767944C5AAQ47549712-6B7FA93C-6DB9-43DB-8D25-B32F366C4FC3Q50793851-11512A5A-6FD4-4425-BB5F-5957E132A865
P2860
Fanconi anaemia and leukaemia - clinical and molecular aspects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@ast
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@en
type
label
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@ast
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@en
prefLabel
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@ast
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@en
P2860
P1476
Fanconi anaemia and leukaemia - clinical and molecular aspects.
@en
P2093
Inderjeet Dokal
Marc Tischkowitz
P2860
P304
P356
10.1111/J.1365-2141.2004.05023.X
P407
P577
2004-07-01T00:00:00Z